Troy Lund is an Oncology physician affiliated with University of Minnesota Medical Center. OpenAlex indexes 383 publications with 17,145 citations (h-index 49); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Hematology-Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
420 Delaware St SE
Minneapolis, MN 554550341
Telephone
612-273-3000Registry record last updated 20 Feb 2013.
Clinical trials
- Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation
Sponsor: Masonic Cancer Center, University of Minnesota
- Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Sponsor: Masonic Cancer Center, University of Minnesota
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tanabe Pharma America, Inc.Program year20251 payment
- Medexus Pharma, Inc.Program year20251 payment
- SANOFI US SERVICES INC.Program year20236 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2011–2020 per NIH RePORTER. The latest:
- Revealing the Mechanisms and Physiology of Peroxisome Transfer in Stem Cell Therapy
University of Minnesota
FY2020$192,500R21OD027047 - Revealing the Mechanisms and Physiology of Peroxisome Transfer in Stem Cell Therapy
University of Minnesota
FY2019$231,000R21OD027047
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy
Expert Opinion on Biological Therapy
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Susan Kline, MD
University of Minnesota Medical Center
Thaddeus Walczak, MD
University of Minnesota Medical Center
Jay Krachmer, MD
University of Minnesota Medical Center
Patricia Ferrieri, MD
University of Minnesota Medical Center
Carl June, MD
University of Pennsylvania
Christopher Benz, MD
Buck Institute for Research on Aging
Christina Fitzmaurice, MD
Gundersen Health System
Beth Karlan, MD
Cedars-Sinai Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”